Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.007 USD 16.67% Market Closed
Market Cap: 22.8m USD
Have any thoughts about
Medivolve Inc?
Write Note

Medivolve Inc
Other Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medivolve Inc
Other Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Assets CAGR 3Y CAGR 5Y CAGR 10Y
Medivolve Inc
OTC:MEDVF
Other Assets
CA$394.8k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Andlauer Healthcare Group Inc
TSX:AND
Other Assets
CA$192.9m
CAGR 3-Years
95%
CAGR 5-Years
58%
CAGR 10-Years
N/A
WELL Health Technologies Corp
TSX:WELL
Other Assets
CA$508.1m
CAGR 3-Years
66%
CAGR 5-Years
127%
CAGR 10-Years
N/A
dentalcorp Holdings Ltd
TSX:DNTL
Other Assets
CA$2.2B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
KDA Group Inc
XTSX:KDA
Other Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Healwell Al Inc
TSX:AIDX
Other Assets
CA$12.3m
CAGR 3-Years
335%
CAGR 5-Years
141%
CAGR 10-Years
N/A
No Stocks Found

Medivolve Inc
Glance View

Market Cap
22.8m USD
Industry
Health Care

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

MEDVF Intrinsic Value
0.004 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is Medivolve Inc's Other Assets?
Other Assets
394.8k CAD

Based on the financial report for Dec 31, 2023, Medivolve Inc's Other Assets amounts to 394.8k CAD.

Back to Top